Correction: In vitro drug testing using patient-derived ovarian cancer organoids

Lin-Yu Chen^#¹, Yu-Ting Chou^#¹, Phui-Ly Liew^{2

3}, Ling-Hui Chu¹, Kuo-Chang Wen^{1

4}, Shiou-Fu Lin², Yu-Chun Weng⁵, Hui-Chen Wang^{4

6}, Po-Hsuan Su⁷, Hung-Cheng Lai^{8

9

10

11}

Affiliations

¹ Department of Obstetrics and Gynecology, Shuang Ho Hospital, Taipei Medical University, New Taipei City, 23561, Taiwan.
² Department of Pathology, Shuang Ho Hospital, Taipei Medical University, New Taipei City, 23561, Taiwan.
³ Department of Pathology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, 11031, Taiwan.
⁴ Department of Obstetrics and Gynecology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, 11031, Taiwan.
⁵ Translational Epigenetics Center, Shuang Ho Hospital, Taipei Medical University, New Taipei City, 23561, Taiwan.
⁶ Department of Obstetrics and Gynecology, Tri-Service General Hospital, National Defense Medical Center, Taipei, 11490, Taiwan.
⁷ College of Health Technology, National Taipei University of Nursing and Health Sciences, Taipei, 11219, Taiwan.
⁸ Department of Obstetrics and Gynecology, Shuang Ho Hospital, Taipei Medical University, New Taipei City, 23561, Taiwan. hclai30656@gmail.com.
⁹ Department of Obstetrics and Gynecology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, 11031, Taiwan. hclai30656@gmail.com.
¹⁰ Translational Epigenetics Center, Shuang Ho Hospital, Taipei Medical University, New Taipei City, 23561, Taiwan. hclai30656@gmail.com.
¹¹ Department of Obstetrics and Gynecology, Tri-Service General Hospital, National Defense Medical Center, Taipei, 11490, Taiwan. hclai30656@gmail.com.

^# Contributed equally.

Published Erratum

Lin-Yu Chen et al. J Ovarian Res. 2024.

. 2024 Dec 5;17(1):243.

doi: 10.1186/s13048-024-01559-1.

Lin-Yu Chen^#¹, Yu-Ting Chou^#¹, Phui-Ly Liew^{2

3}, Ling-Hui Chu¹, Kuo-Chang Wen^{1

4}, Shiou-Fu Lin², Yu-Chun Weng⁵, Hui-Chen Wang^{4

6}, Po-Hsuan Su⁷, Hung-Cheng Lai^{8

9

10

11}

¹ Department of Obstetrics and Gynecology, Shuang Ho Hospital, Taipei Medical University, New Taipei City, 23561, Taiwan.
² Department of Pathology, Shuang Ho Hospital, Taipei Medical University, New Taipei City, 23561, Taiwan.
³ Department of Pathology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, 11031, Taiwan.
⁴ Department of Obstetrics and Gynecology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, 11031, Taiwan.
⁵ Translational Epigenetics Center, Shuang Ho Hospital, Taipei Medical University, New Taipei City, 23561, Taiwan.
⁶ Department of Obstetrics and Gynecology, Tri-Service General Hospital, National Defense Medical Center, Taipei, 11490, Taiwan.
⁷ College of Health Technology, National Taipei University of Nursing and Health Sciences, Taipei, 11219, Taiwan.
⁸ Department of Obstetrics and Gynecology, Shuang Ho Hospital, Taipei Medical University, New Taipei City, 23561, Taiwan. hclai30656@gmail.com.
⁹ Department of Obstetrics and Gynecology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, 11031, Taiwan. hclai30656@gmail.com.
¹⁰ Translational Epigenetics Center, Shuang Ho Hospital, Taipei Medical University, New Taipei City, 23561, Taiwan. hclai30656@gmail.com.
¹¹ Department of Obstetrics and Gynecology, Tri-Service General Hospital, National Defense Medical Center, Taipei, 11490, Taiwan. hclai30656@gmail.com.

^# Contributed equally.

No abstract available

Erratum for

In vitro drug testing using patient-derived ovarian cancer organoids.
Chen LY, Chou YT, Liew PL, Chu LH, Wen KC, Lin SF, Weng YC, Wang HC, Su PH, Lai HC. Chen LY, et al. J Ovarian Res. 2024 Oct 2;17(1):194. doi: 10.1186/s13048-024-01520-2. J Ovarian Res. 2024. PMID: 39358778 Free PMC article.

1. Chen LY, Chou YT, Liew PL, et al. In vitro drug testing using patient-derived ovarian cancer organoids. J Ovarian Res. 2024;17:194. 10.1186/s13048-024-01520-2. - PMC - PubMed